Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

CONTINUED EFFORTS WITHIN NEW PRODUCT AREA DIGITAL IDENTITY

YEAR-END REPORT FOR THE PERIOD JANUARY TO DECEMBER 2018 FOURTH QUARTER  · Net sales for the remaining operation totaled SEK 13.9 (14.2) million. · The operating profit/loss for the remaining operation totaled SEK -14.3 (-5.3) million.  · The profit/loss for the remaining operation totaled SEK -15 (-12.0) million.  · Earnings per share for the remaining operation totaled SEK -0.04 (-0.03).  · Earnings per share for the total operation totaled SEK -0.04 (-0.03). · Cash flow from total operating activities totaled SEK -9.1 (3.1) million. FULL-YEAR PERIOD, JANUARY-

YEAR-END REPORT, January–December 2018

A solid quarter and best year ever Fourth quarter of 2018 · Consolidated net sales increased by 24 percent to SEK 692 m (558), of which organic growth amounted to 6 percent. Acquisitions contributed by 14 percent and currency by 4 percent · Net sales in Products & Solutions amounted to SEK 516 m (382) and Installation Services to SEK 198 m (192) · EBITDA before items affecting comparability increased by 16 percent to SEK 66 m (57) · Operating profit (EBIT) before items affecting comparability increased by 18 percent to SEK 52 m (45) · Operating profit (EBIT) amounted to

Raisio plc: Notice of General Meeting

Raisio plc, Stock Exchange Release 12 February 2019 NOTICE OF GENERAL MEETING The shareholders of Raisio plc are hereby invited to the Annual General Meeting which will be held on Tuesday 19 March 2019 at 14.00 (2 p.m.) at Turku Fair Center, address Messukentänkatu 9-13, FI-20210 Turku, Finland. Reception of the participants who have registered to the meeting commences at 13.00 (1 p.m.). The following issues will be handled in the meeting: 1. Opening of the meeting 2. Getting the meeting organized 3. Election of examiners of the minutes and supervisors of counting of

The Nomination Committee proposes Ann-Sofie Nordh to the myFC Board of Directors

The nomination committee for myFC proposes that Ann-Sofie Nordh, Vice President and Head of Investor Relations at Sandvik AB, is elected member of the Board of Directors at the upcoming Annual General Meeting of myFC.Ann-Sofie Nordh is currently Vice President and Head of Investor Relations at high-tech engineering group Sandvik. Prior to that, she has more than 20 years of experience from working in the financial industry in Stockholm and London. “Ann-Sofie Nordh is highly merited and adds valuable experience and competence to the board of myFC in, among other areas, investor relations,”

Cxense ASA – Commencement of the subscription period for the rights issue

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, HONG KONG OR SOUTH AFRICA, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. As previously announced, Cxense ASA (the "Company") will carry out a fully underwritten rights issue (the "Rights Issue") of 12,857,142 new shares in the Company (the "Offer Shares"), raising gross proceeds of approximately

Year-end report January - December 2018

JANUARY - DECEMBER 2018 · Income, MSEK 1,064 (1,031) · Profit after tax, MSEK 1,615 (1,215) · Profit after tax per share, SEK 9.63 (7.24) OCTOBER - DECEMBER 2018 · Income, MSEK 317 (247) · Profit after tax, MSEK 308 (279) · Profit after tax pre share, SEK 1.84 (1.66) SIGNIFICANT EVENTS DURING AND AFTER THE QUARTER · Nyfosa was listed on the Nasdaq Stockholm, Large Cap, on November 23. · After the end of the quarter, Nyfosa's joint venture, Söderport, divested a part-owned property in Torslanda. · The Board proposes that the Annual General Meeting

Year-end report 2018 and quarterly report October – December 2018

Quote from Therese Hillman, Group CEO“In the fourth quarter, several of our new games performed well and revenues increased by 9.5 percent (3.9 percent in euro). The adjusted EBIT margin improved to 37.3 percent, supported by higher volumes, the weaker Swedish krona, and better cost control. I look forward to another busy year as we continue to strive for higher organic growth with maintained cost control.” Fourth quarter 2018 · Revenues for the fourth quarter amounted to 465 (425) SEKm · EBITDA was 204 (194) SEKm, a margin of 43.9 (45.7)%. Reorganization-related costs of 22

Fourth quarter and year-end report - 31 December 2018

Fourth quarter 2018 (third quarter 2018) · Production from Blocks 3&4, Oman, amounted to 11,898 bopd (11,857 bopd) · Revenue and other income of MUSD 44.4 (MUSD 42.3) · EBITDA of MUSD 30.8 (MUSD 30.1) · Net result of MUSD 19.9 (MUSD 18.2) · Earnings per share amounted to USD 0.58 (USD 0.53) · Blocks 3&4: Appraisal programme of 2017 discoveries continued with three wells drilled · Block 49: 253 km2 of 3D and 299 km of 2D seismic acquired Reserves and Contingent Resources · 2P internal reserve replacement ratio of 177 percent · Year-end 2018 2P Reserves of 25,

Year-end report 2018: Wihlborgs posts record strong results and continued growth

· Rental income rose 14 percent to SEK 2,684 million (2,351) · Operating surplus rose 13 percent to SEK 1,941 million (1,717) · Income from property management rose 19 percent to SEK 1,406 million (1,179). · Profit for the period totalled SEK 2,403 million (2,568), corresponding to earnings per share of SEK 15,63 (16,71) · The Board of Directors proposes a dividend of SEK 3.75 (3.13) per share“We close the books on another record year. Each year since we first listed on the stock exchange in 2005 has been a record year — irrespective of whether one looks at rental income,

Raisio plc: Financial Statements Bulletin 2018

Raisio plc, Financial Statements Bulletin 12 February 2019 at 8.30 Finnish time RAISIO IS NOW AN INTERNATIONAL BRAND HOUSE FOCUSING ON HEALTHY FOOD January-December 2018, continuing operations · The Group’s net sales totalled EUR 228.2 (234.6) million. Comparable EBIT was EUR 25.6 (35.9) million, accounting for 11.2 (15.3) % of net sales. EBIT was EUR 16.6 (54.1) million, accounting for 7.3 (23.0) % of net sales. EBIT for the comparison year includes sales profits of EUR 28.0 million for the Southall factory property. · The Healthy Food Division’s net sales totalled EUR 201.1 (

Orkla ASA: Mandatory notification of trade - primary insiders

Grace Reksten Skaugen, Deputy Chair of the Board of Orkla, has, through her wholly owned company Infovidi Board Services Ltd, bought 9,600 shares at a price of NOK 67.13 per share. Following this transaction, Reksten Skaugen and related parties own 18,100 shares in Orkla. Lars Dahlgren, Member of the Board of Orkla, has bought 1,000 shares at a price of NOK 67.10 per share. Following this transaction, Dahlgren and related parties own 7,500 shares in Orkla. Håkon Mageli, Group Director Corporate Communications and Corporate Affairs at Orkla, has bought 15,000 shares at a price of NOK

NRC Group - Fourth quarter 2018 result report and presentation

Today, 12 February 2019, NRC Group has released its financial results for the fourth quarter of 2018. The company will present the results at 12.00 AM (CET) at SEB offices, Filipstad Brygge 1, 8th floor, Oslo. The presentation will be held by CEO Øivind Horpestad and CFO Dag Fladby. If you want to attend the presentation, please register by email to invitations@seb.no. Below you will find a summary and highlights from the report. Acquisition of VR Track OY -       Creating the largest Nordic rail infrastructure player with the acquisition of Finnish VR Track Oy -       A

Oululainen Reissumies to reduce the amount of plastic in packaging: 10 million fewer bread bags per year

Fazer Bakeries is cutting down on the use of plastic in Oululainen Reissumies packaging. The changes result in a reduction of more than 25,000 kilos of plastic every year, which is equivalent to 10 million Reissumies bags. The new packaging arrives in shops in mid-February.The new, custom-made package fits Reissumies better than the old one. The amount of plastic is reduced by making the package a snugger fit and the material thinner. “We will be analysing all the packaging we use. The reduction of plastic we've achieved through changes to the packaging of Oululainen Reissumies

Fourth quarter concludes an extraordinary year for Elkem

Oslo, 12 February 2019: Elkem completes a strong 2018, but fourth quarter earnings hampered by weaker market sentiment, especially in China. Sales prices and volumes in China have been affected by lower demand and maintenance stops. Considering the challenging market conditions the result was relatively strong. Total operating income for the fourth quarter 2018 was NOK 6,265 million, which was in line with fourth quarter 2017. EBITDA for the quarter amounted to NOK 974 million, down from NOK 1,078 million in the corresponding quarter last year. Earnings per share (EPS) was NOK 0.64 in

BerGenBio ASA: Results for the Fourth Quarter and Full Year 2018

Important progress made in 2018: · PoC for bemcentinib reported in multiple cancer indications · AML/MDS and NSCLC confirmed as target indications for forward development towards registration, starting in 2019 · Increasing confidence in bemcentinib safety profile with more than 250 patients dosedBergen, Norway, 12 February 2019 – BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for multiple cancer indications, announces its results for the fourth quarter and full year 2018. A presentation of the results by

Kværner ASA: The Board of Directors' proposal to Kværner ASA's Annual General Meeting

12 February 2019 - The Annual General Meeting of Kværner ASA will be held on 28 March 2019 at 12:00 CET at Oksenøyveien 10, at Fornebu, Norway. Kvaerner has in recent years completed several significant projects with predictable performance and sound results, which has resulted in a strong financial platform. At a meeting on 11 February 2019, the Board of Directors resolved to propose to the Annual General Meeting of Kvaerner that a dividend of NOK 1.00 per share is approved. Subject to approval by the Annual General Meeting, the dividend payment will take place on or about 11 April 2019 to

Kværner ASA: Kvaerner's orderbook up, revenues up, dividend proposed

12 February 2019 - Kvaerner delivered sound results for the fourth quarter and full year 2018, in line with what has previously been communicated. For the second year in a row, the orderbook increased. Order backlog at the end of 2018 was NOK 10 625 million versus NOK 8 077 million a year before. Also consolidated operating revenues increased, to NOK 7 220 million for 2018 against NOK 6 536 million for 2017. The market outlook is positive and Kvaerner's financial platform is strong. A dividend of NOK 1 per share is proposed.For the Field Development segment, which includes joint ventures,

Lehto Group Plc: Lehto will continue share-based incentive plans for key employees in 2019

Lehto Group PlcStock exchange release12 February 2019 at 7.35 pm (EET)Lehto Group Plc's Board of Directors has decided to continue the share-based incentive plans for Group key employees, adopted in 2016. The aim of the plans is to align the objectives of the shareholders and the key employees in order to increase the value of the company in the long term and to commit key employees to the company. Long-term incentive plan: The long-term incentive plan has a one-year vesting period and a two-year restriction period. Targets are set for the key employees for each vesting period,

Norway Royal Salmon: Q4 18 – Highest Operational EBIT in the history of NRS

Today Norway Royal Salmon (NRS) reports an operational EBIT of MNOK 232 for the fourth quarter 2018 and EBIT per kg of NOK 17.73. Corresponding figures for the same quarter last year were MNOK 95 and NOK 15.51. - Today we report the highest operational EBIT in the history of NRS for both a quarter and a financial year. We are pleased that Region North continues the positive development in production costs, however biological challenges in Region South are reducing the result says CEO Charles Høstlund. For the financial year of 2018, NRS has operating revenues of more than NOK 5

Lehto Group Plc: Net sales EUR 721.5 million, up 20.7%. Operating profit EUR 37.2 million, or 5.2% of net sales

Lehto Group PlcFinancial statement bulletin 1 January - 31 December 201812 February 2019 at 7:30 a.m.Net sales EUR 721.5 million, up 20.7%. Operating profit EUR 37.2 million, or 5.2% of net sales  This report has been prepared in accordance with the IAS 34 standard. The company complies with half-yearly reporting according to the Finnish Securities Markets Act. The financial statement bulletin is unaudited. Figures in brackets refer to the corresponding period of the previous year, unless otherwise stated. Summary 2018 Group 1-12/2018 1-12/2017 10-12/2018 10-

Moberg Pharma AB Year-end report 2018

MAJOR TRANSFORMATION OF THE COMPANY AFTER A STRONG YEAR This year-end report 2018 is made public in advance due to the transaction press release announced earlier today regarding the divestment of Moberg Pharma’s OTC-business.PERIOD (FULL YEAR 2018) · Net revenue SEK 439.0 million (439.0, current portfolio 369.2). Current portfolio growth of 16%* · EBITDA SEK 101.7 million (89.4) including, and SEK 96.7 million (76.4) excluding, capital gains** · EBITDA margin 23% (20) · EBITDA for commercial operations SEK 123.1 million (106.0) · Operating profit (EBIT) SEK 64.8 million

Moberg Pharma divests its OTC-business for USD 155 million and secures new funding for MOB-015 in transformational transaction

STOCKHOLM, February 12th, 2019. Moberg Pharma AB (publ) (“Moberg Pharma” or the “Company”) (OMX: MOB) today announces that it has entered into agreement with a holding company owned by RoundTable Healthcare Partners and Signet Healthcare Partners (the “Purchaser”) to divest MPJ OTC AB and Moberg Pharma North America LLC, which at closing will hold Moberg Pharma’s entire OTC-business, for a cash consideration of USD 155 million (equivalent of SEK 1,431 million[1] ) adjusted for working capital, resulting in a capital gain of approximately SEK 500 million and

Lucara 2018 Year End Results to be Released Thursday, February 21, 2019

Vancouver, February 11, 2019 /CNW/ - (LUC – TSX, LUC – BSE, LUC – Nasdaq Stockholm) Lucara Diamond Corp. (“Lucara” or the “Company”) announces that it will be publishing its 2018 Year End Results on Thursday, February 21, 2019, after the market close in North America. The Company will host a conference call and webcast to discuss the results on Friday, February 22, 2019, at 7:00 a.m. Pacific, 10:00 a.m. Eastern, 3:00 p.m. UK, 4:00 p.m. CET. CONFERENCE CALL:Please call in 10 minutes before the conference call starts and stay on the line (an operator will be available to assist you).

There are no items matching the current filter
There are no more items matching the current filter
Back to top